Classes
- Clinical 10 days - Department of Oncology +1D0110ONK | Second Faculty of Medicine
- Clinical Radiotherapy +1D0503007 | Second Faculty of Medicine
- Radiotherapy +1D0505002 | Second Faculty of Medicine
- Clinical Radiotherapy - Training +1D0505009 | Second Faculty of Medicine
- OS - Selected chapters from oncologyDVA1099 | Second Faculty of Medicine
Publications
- Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy2016 | Publication without faculty affiliation
- Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy2015 | Publication without faculty affiliation
- Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial2014 | Second Faculty of Medicine
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen2012 | Second Faculty of Medicine
- Prevention, diagnosis and treatment of cancer-associated thromboembolism2023 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- The possibilities of molecular testing of somatic aberrations in tumor tissue using NGS in routine practice - current situation in the Czech Republic2021 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Proton pencil-beam scanning radiotherapy in the treatment of nasopharyngeal cancer: dosimetric parameters and 2-year results2021 | First Faculty of Medicine, Third Faculty of Medicine
- Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes2021 | Central Library of Charles University, Third Faculty of Medicine
- A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)2021 | Publication without faculty affiliation
- Regorafenib for metastatic colorectal cancer: An analysis of a registry-based cohort of 555 patients2020 | Faculty of Medicine in Pilsen, First Faculty of Medicine
Loading network view...